Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia
Observational Study of Tamsulosin in Patients With Benign Prostatic Hyperplasia
Study to describe Tamsulosin prescription characteristics in a representative population of
 patients on treatment for benign prostatic hyperplasia
Inclusion Criteria:

 -  Patients older than 21 years old diagnosed with benign prostatic hyperplasia (BPH),
 who require pharmacological treatment to relieve symptoms and improve their quality of
 life, according to physician's judgment. The study will include naïve patients and
 patients not responding to previous therapy who receive Secotex as alternative or
 complementary treatment. The decision to treat a patient with Tamsulosin must be based
 on the best standard accepted in the clinical practice and must be carried out
 following Secotex (Tamsulosin) prescription information

 Exclusion Criteria:

 -  Patients with known hypersensitivity to Tamsulosin or any of its ingredients, history
 of orthostatic hypotension or severe liver failure, or with any missing data required
 to complete the questionnaire are excluded